Open AccessIncidence of opportunistic infections during ibrutinib treatment for B-cell malignancies
Author(s) -
Kerry A. Rogers,
Luay Mousa,
Qiuhong Zhao,
Seema A. Bhat,
John C. Byrd,
Zeinab El Boghdadly,
Tomas Guerrero,
Lauren Levine,
Fabienne Lucas,
Polina Shindiapina,
Audrey M. Sigmund,
Matthew B. Sullivan,
Tracy Wiczer,
Jennifer A. Woyach,
Farrukh T. Awan
Publication year - 2019
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-019-0481-1
Subject(s) - ibrutinib , medicine , incidence (geometry) , hematology , leukemia , hematologic neoplasms , lymphoma , oncology , immunology , chronic lymphocytic leukemia , cancer , physics , optics